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Summary. The prophage Lv1, harbored by a vaginal Lactobacillus jensenii isolate, was induced by several different anti-
cancer, antimicrobial, and antiseptic agents, suggesting that they contribute to the adverse vaginal effects associated with
their therapeutic use. Of special interest with respect to its novelty was the inducing effect of nonoxynol-9, a non-ionic deter-
gent commonly used as a spermicide. The Lv1 genome consists of a 38,934-bp dsDNA molecule with cohesive ends, in
which 48 ORFs were recognized, and is organized into functional modules. Lv1 belongs to the family Siphoviridae and,
more precisely, to the proposed Sfi21-like genus. The capsid-tail junction of the Lv1 virions is fragile such that most parti-
cles become disrupted, suggesting that the virus is defective and thus unable to generate fertile progeny. However, genome
analysis did not provide evidence of the defective nature of the prophage, other than the finding that its genome is shorter
than those of other, related, phages. Further analysis indicated that prophage Lv1 suffered deletions in its right half to the
extent that it no longer fulfill the minimum packaging limits, thereby generating the observed unstable particles. [Int
Microbiol 2010; 13(3):113-121]
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Introduction
Lactobacilli constitute over 70% of all bacteria sampled from
the vaginas of healthy, fertile women [40,31]. These bacteria
protect the mucosal surface from pathogen colonization by
three complementary mechanisms: (i) direct competition for
attachment to the epithelial surface, (ii) production of antimi-
crobials, such as lactic acid and hydrogen peroxide, and (iii)
co-aggregation with pathogens, further neutralizing their
adherence to the mucosa thus enhancing the antimicrobial
effect of the lactobacilli [5,40].
Based on these properties, lactobacilli have been envis-
aged as probiotic agents in the control of vaginal infections
as well as in relapse prevention [26]. A further advantage of
lactobacilli as vaginal probiotics is that they are naturally
resistant to most antibiotics used, either systemically or in
situ, to combat vaginal disorders. Thus, they are not affected
by metronidazole and clindamycin [24], first-line agents in
the treatment of bacterial vaginosis and, in the case of
metronidazole, for trichomoniasis as well. Furthermore, a
significant proportion is resistant to nonoxynol-9 [24], a
widely used spermicide commonly included in creams and in
condom lubricants. Conversely, vaginal lactobacilli are
extremely susceptible to β-lactams, macrolides, and tetracy-
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cline. However, in the few isolates with moderate resistance
towards the latter two antibiotics, genes encoding ribosomal
protection or antibiotic-efflux proteins, usually linked to con-
jugative transmission of the resistances, have not been
detected [24]. Lactobacilli tend also to be susceptible to anti-
neoplastic drugs, many of which are active on gram-positive
bacteria [32]. The sensitivity of lactobacilli to these drugs
might explain the increase in vaginal disorders observed after
treatment of systemic infections and tumors [9,36]. The
chemotherapeutics probably permeate the vaginal surface
and inhibit the development of indigenous lactobacilli, thus
allowing the overgrowth of minor components of the vaginal
microbiota, such as Candida albicans and Gardnerella vagi-
nalis, or even colonization by enteric microorganisms.
In a previous report, we postulated that activation of the
SOS response plays a complementary role in the develop-
ment of vaginal side effects produced by systemic radio- and
chemotherapy, through induction of prophages resident in the
genomes of vaginal lactobacilli [23]. This conclusion was
based on the following: firstly, most antineoplastic agents
and several antimicrobials inhibit DNA synthesis, which is
known to activate the SOS response [17,37]; furthermore,
even certain β-lactams and a septum-blocking bacteriocin
exhibit the same property [22,27]. Secondly, lysogeny is
widespread among environmental lactobacilli [8] and it has
been shown that a component of tobacco smoke induces a
prophage harbored by a vaginal Lactobacillus [28], which
might explain the high frequency of bacterial vaginosis
observed in female smokers [16]. However, we could not iso-
late any Lactobacillus phages from vaginal exudates nor did
we obtain viral progeny after treatment of 45 strains of vagi-
nal lactobacilli with mitomycin C. Nevertheless, lysogeny
appeared to be widespread since phage-specific sequences
could be amplified from more than one-third of the strains. In
some cases, these sequences were responsive to SOS activa-
tion, as judged by their concentration increase following
challenge with mitomycin C. Finally, some of the induced
culture supernatants were inhibitory when placed over lawns
of other strains but never led to the formation of lytic plaques
upon dilution. Taken together, these findings were considered
indicative of the presence of defective prophages in a sub-
stantial proportion of Lactobacillus vaginal isolates [23]. It
should be noted that most of these lactobacilli produce
hydrogen peroxide (H2O2), which has been shown to be a
SOS-activating compound [24,25], suggesting that H2O2 pro-
motes the selection of bacterial cells harboring SOS-insensi-
tive, defective prophages [23].
That study provided further proof of the involvement of
prophage induction in the increase in vaginal disorders that
follow radio- and chemotherapy. In fact, the culture super-
natant of a L. jensenii strain inhibitory to other lactobacilli
contained virions with isometric capsids and long, non-con-
tractile tails. This allowed classification of the virus, named
Lv1, within the family Siphoviridae [23]. The current report
addresses the responsiveness of this prophage towards treat-
ment with potentially SOS-activating agents. Furthermore,
the structural and genetic characteristics of this virus are dis-
cussed, as are the reasons why it might have become defec-
tive. 
Materials and methods
Bacterial strain and culture conditions. Lactobacillus jensenii
Lv39 was isolated from the vaginal exudate of a healthy, reproductive-aged
woman [24]. It was grown on MRS agar as previously described [23].
Prophage excision assays. Prophage excision assays were carried out essen-
tially as described elsewhere [32]. Briefly, samples (25 ml) of L. jensenii cul-
tures in the early exponential phase (OD600 = 0.1) were treated with the fol-
lowing potentially SOS-inducing agents [usually at half of the minimal
inhibitory concentration (MIC)]: H2O2 (1 mM), UV radiation (1 J/m2), mito-
mycin C (0.45 µg/ml), mitramycin (0.03 µg/ ml), ampicillin (0.5 µg/ml), bil-
iary salts (10 mg/ml), and nonoxynol-9 (0.4%). Incubation was continued
under the same conditions and aliquots of 100 µl were taken from the cul-
tures every 30 min and immediately frozen. Real-time PCR samples were
prepared in a final volume of 15 µl, including 1.25 µl of the cell culture,
using the PCR Q SYBR Green Supermix (Bio-Rad) according to the manu-
facturer’s instructions. The primers used matched phage sequences placed at
each side of the attP attachment site: 5′-GTCACAGTAGTTACAA-
GAGTTCTGCG-3′ and 5′-CAGCGACGTGGCAAAC-3′. Amplifications
were carried out on a iCycler iQ Multicolor Real-Time PCR detection sys-
tem (Bio-Rad) with a thermocycle profile as follows: stage 1, 95°C (10 min);
stage 2, 30 cycles of 95°C (1 min), 50°C (1.5 min), and 72°C (1 min). The
data obtained were recorded as threshold cycle (CT) values; i.e., the cycle
number during which the fluorescence signal crossed the threshold set by the
manufacturer of the thermocycler.
Purification and structural characterization of virions.
Virions were purified as described previously [23] through precipitation with
polyethylene glycol from induced L. jensenii Lv39 cultures and banding into
two successive CsCl-gradient centrifugations. The concentrated suspensions
were stored at 4ºC in the presence of CsCl. For electron microscopy, drops
of dialyzed virion suspensions were placed onto carbon-coated grids and
then negatively stained with 2% (w/v) uranyl acetate. Phage structural pro-
teins were analyzed by heating dialyzed suspensions at 70ºC for 15 min, fol-
lowed by incubation for 1 h with 1 µg DNase I/ml at 37ºC. The samples were
then subjected to SDS-PAGE (6% and 12% acrylamide in the stacking and
separating gels, respectively) and stained with Coomassie brilliant blue fol-
lowing standard methods. The bands of interest were excised manually,
digested with porcine trypsin (Promega), and the resulting peptides analyzed
by MALDI-TOF-TOF mass spectrometry, essentially as previously
described [15].
Phage DNA purification, sequencing, and analysis.
Genomic DNA was extracted from purified virions using the phenol–chloro-
form method after disruption of the particles by incubation in a 50 mM
EDTA solution at 70ºC. Restriction enzymes were used as indicated by the
supplier (Takara). For sequencing, approximately 10 µg of phage DNA was
sheared by sonication, size-selected (2–3 kbp), and cloned into pUC18.
Individual clones were sequenced and assembled. Trace assembly was done
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with the phredPhrap package [12]. Generally, the assembled phage genome
sequences had at least five-fold coverage in both orientations. Primer walk-
ing was sometimes used to close gaps in the sequence. 
The cos sites were localized through comparisons of the restriction pat-
terns of ligated and unligated DNA samples. To obtain the sequence of the
single-stranded cos extensions, the ends of the DNA were sequenced direct-
ly using primers that pointed outwards. The nucleotide sequences obtained
were aligned with that of the circular genome and found to overlap by 12
bases that were considered to constitute the cosN site.
Open reading frames (ORFs) were predicted with Clone Manager 7 and
ORF Finder [http://ncbi.nlm.nih gov/gorf/gorf.html] and by visual inspec-
tion. The primary nucleotide sequence was scanned in all reading frames for
the start codons AUG and GUG with a threshold of 50 codons. BLASTX and
BLASTP [http://www.ncbi.nlm.nih.gov/blast/Blast.cgi] were used to search
for homologous proteins. Structural predictions and motif searches were per-
formed with InterProScan [http://www.ebi.ac.uk/InterProScan/], Pfam
[http://pfam.sanger.ac.uk/search?tab=searchSequenceBlock], YASPIN
[http://zeus.cs.vu.nl/programs/yaspinwww/] and TMHMM Server v. 2.0
[http://www.cbs.dtu.dk/services/TMHMM-2.0/]. Sequences of the σ70 pro-
moter were identified using Bprom [http://www.softberry.com]. Putative ter-
minator sequences were detected with the Terminator function of GCG (ver-
sion 10.2). Putative tRNA encoding genes were searched for with
tRNAscan-SE 1.21 [http://selab.janelia.org/tRNAscan-SE/]. Prediction of
+1 and –1 frameshifting was carried out with FSFinder 2 [http://
wilab.inha.ac.kr/fsfinder2/]. 
The accession number for the phage Lv1 genome is EU871039.
Results and Discussion
Inducibility of the Lv1 prophage. Phages modulate
the composition of bacterial communities through a “kill the
winner” mechanism, thus contributing to the maintenance of
balanced ecosystems. This mechanism appears to be restrict-
ed in the vagina due to the generation of H2O2 by indigenous
lactobacilli. H2O2-mediated activation of the SOS response,
by inducing resident prophages, may select for bacteria har-
boring defective viruses unable to generate progeny [23]. The
SOS response can also be activated by many of the drugs
used to treat infections and cancer as well as by therapeutic
radiation. Some of these agents were therefore examined
regarding their ability to induce prophage Lv1, resident in the
genome of the vaginal isolate L. jensenii Lv39. As represen-
tative anticancer drugs, mitomycin C and mitramycin were
chosen (others, such as rebeccamycin, could not be used
because the strain was not susceptible). To mimic the anti-
bacterial effect of radiotherapy, ultraviolet light was chosen.
Since vaginal lactobacilli are naturally resistant to metronida-
zole and quinolones [24], the two most conspicuous antibac-
terial DNA inhibitors, ampicillin was used as it has been
shown to activate the SOS response in Escherichia coli [27].
Finally, both nonoxynol-9, the most widely used spermicide,
and bile salts, due to the possibility of passage of lactobacil-
li from the enteric tract to the vagina, were tested [3]. 
Since Lv1 did not produce lytic plaques on any of a col-
lection of 45 strains of vaginal lactobacilli [23], converging
oligonucleotides, located at each side of the attP attachment
site, were designed to quantify the induction of the phage’s
lytic cycle using real-time PCR [32].
All conditions tested, with the exception of bile salts,
induced the lytic cycle of Lv1 at least as efficiently as
achieved with H2O2, when used at concentrations that
reduced but did not suppress the growth of L. jensenii Lv39
(Fig. 1A,D). In the case of the antitumor compounds tested
and UV radiation, this result was expected because of their
interactions with DNA: mitomycin C induces cross-linking
of the two strands [34], mitramycin interacts with the minor
groove and inhibits transcription [21], and UV induces the
formation of pyrimidine dimers. Ampicillin most likely acti-
vated the DpiBA two-component signal transduction system,
as it does in E. coli. DpiA binds A+T-rich sequences at the
origin of replication, thus competing with DnaA and DnaB
and transiently inhibiting bacterial cell division, which, in
turn, activates the SOS response [27]. Note that homologues
to dpiA and to dpiB were recognized in the sequenced
genomes of two Lactobacillus rhamnosus strains
(NC_013198-1 and NC_013199-1). The inducing effect of
nonoxynol-9 deserves further study. This non-ionic detergent
reduces the surface tension of the acrosomal membrane,
thereby inhibiting the movement of spermatozoa. It may thus
be assumed that the spermicide’s effect on bacteria involves
a disturbance of the phospholipid bilayer structure of mem-
branes, a mechanism of action that has not previously been
linked to SOS activation. However, only about half of the
vaginal lactobacilli strains challenged with nonoxynol-9
were found to be susceptible [24]. This absence of a general
effect and the capacity of the drug to induce the lytic cycle of
Lv1 suggest that, in bacteria, the membrane might not be the
main target of nonoxynol-9. 
The increase in vaginal disorders that is commonly asso-
ciated with cancer and antimicrobial therapies might be due,
in part, to the induction of Lactobacillus resident prophages
which, as is the case with Lv1, lyse their host cells, thus con-
tributing to depletion of the beneficial Lactobacillus-domi-
nant vaginal microbiota and subsequent colonization by
undesirable microorganisms. However, this effect would be
partial, as 50% of lysogenic vaginal lactobacilli harbor defec-
tive prophages unresponsive to SOS-activating conditions
[23].
Structural characteristics of Lv1 virions.
Electron microscopy of CsCl-purified Lv1 suspensions
showed complete virions and an abundance of both empty
capsids and isolated tails (Fig. 2A), although the samples
were examined as soon as soon as possible to avoid phage
disruption due to storage. Since CsCl-gradients separate par-
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ticles as a function of their buoyant density, the band extracted
had to be comprised exclusively of complete virions. In fact,
viral DNA was easily obtained from these suspensions,
which indicates that it was packaged into viral capsids. These
findings suggest that the capsid-tail junction of Lv1 is unsta-
ble such that the virus is incapable of forming lytic plaques
due not only to the lack of an appropriate host but also to the
instability of its virions.
Analysis of the phage Lv1 genome. To determine
the reason(s) for Lv1 virion fragility, its genome was
sequenced and analyzed. The viral genome was located in a
dsDNA molecule 38,934 bp long. Its G+C content was deter-
mined to be 37%, which is within the range of the values
recorded for Lactobacillus strains of species closely related
to L. jensenii [2,4].
Treatment of the DNA with T4 DNA-ligase revealed the
presence of cohesive ends (Fig. 2B), consisting of 13-bp sin-
gle-stranded 3´ extensions with the sequence 5´-CACA-
CAACAGGGG-3´. This sequence is 70% identical to the
cosN site of AT3, a Lactobacillus casei phage [20], and 60%
identical to a sequence located in the 5´ vicinity of the small
terminase gene of a prophage harbored in the Lactobacillus
fermentum genome (accession number NC_010610). In the
genome of Lv1, 48 putative ORFs using more than 50 codons
were recognized (Fig. 3A, Table S1), all of which contained
an AUG start codon. About 12.7% of the genome was non-
coding; the start codon of four ORFs overlapped with the
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Fig. 1. Influence of sublethal concentrations of several agents on the growth (A,C) and generation of
autonomous Lv1 genomes (B,D) by a lysogenic culture of Lactobacillus jensenii Lv39, as measured by real-
time PCR of the attP segment. Note that on the ordinate axis the threshold cycle (CT) values are depicted in
descending order to provide a more intuitive representation (the lower the CT value, the higher the initial con-
centration of the DNA segment being amplified). (A,B) Open circles, untreated cultures; closed triangles, 1
mM H2O2 (positive control); closed circles, 10 mg biliary salts/ml; open triangles, 0.4% nonoxynol-9; open
squares, 0.5 µg ampicillin/ml. (C,D) Open circles, untreated cultures; closed triangles, 1 mM H2O2; closed cir-
cles, 0.45 µg mitomycin C/ml; open triangles, 0.03 µg mitramycin/ml; open squares, 1 J UV radiation/m2. Error
bars represent the standard deviations of three independent experiments.
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stop codon of the previous one and nine had their ends inside
the following ORF, indicative of expression through poly-
cistronic mRNAs and translational coupling. Gene transcrip-
tion was from right to left for the genes presumed to be
involved in the establishment of the lysogenic cycle, i.e.,
from ORF26 to ORF24 and including those encoding the CI-
like repressor and the integrase. All but one of the remaining
ORFs (ORF29) read from left to right, starting at the cro
homologue (ORF27), continuing through the cohesive ends,
and finishing at the attP site, where a ρ-independent termina-
tor was detected.
The genome was annotated after comparison with current
databases (Fig. 3A, Table S1). Significant matches were
obtained for 31 ORFs and biological functions were assigned
to most of them. No tRNA genes were found. As is the case
for most phages that infect lactobacilli [8], the Lv1 genome
is divided into several modules comprising groups of genes
whose products are involved in a common function. 
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Fig. 2. (A) Electron micrograph of an Lv1 phage suspension
obtained upon treatment of its host, Lactobacillus jensenii
Lv39, with mitomycin C and purification of the virions
through buoyant density CsCl gradient centrifugation. (B)
Restriction pattern (EcoRV) of ligated (lane 2) and unligated
(lane 3) DNA. The arrows point to the bands in the unligated
DNA lane and to the result of their fusion after treatment with
T4-ligase. (C) SDS-PAGE of the major structural proteins of
Lv1.
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The left extreme of the genome is made up of the DNA pack-
aging cluster, including the genes encoding the small and
large terminase subunits. The product of the latter gene has a
motif typical of large terminases that render 3´ protruding
cohesive ends [10], which is in agreement with our experi-
mental data. 
The capsid morphogenesis module comprises ORF3 and
ORF4. Gp3 shares motifs with phage portal proteins, while
gp4 is a composite protein of 615 amino acids that in the data-
bases matches proteases in its amino terminus (up to residue
174) and major head proteins in its carboxyl terminus, with
several α-helix motifs predicted in its middle part. MALDI-
TOF/TOF analysis of the most abundant Lv1 virion protein
identified peptides that matched gp4 from its 365th residue
onwards, suggesting that native gp4 is autoprocessed by its
protease domain to give rise to the major capsid polypeptide.
This may explain its apparent size of 37 kDa, as observed by
SDS-PAGE (Fig. 2C). The α-helices found in the middle of
gp4 are characteristic of scaffold proteins, which together
with their location, i.e., fused to the major capsid polypeptide,
indicate that this is precisely the function of the central part of
gp4. The products of ORF5 to ORF8 present regions of
homology with Lactobacillus phage proteins putatively
involved in the morphogenesis of viral neck structures.
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Fig. 3. (A) Physical and genetic map of the phage Lv1 and alignment with those of phages adh and Sal2. The grey spaces linking ORFs between genomes
indicate degrees of amino acid identity: light gray, between 25 and 39%; dark gray, between 40 and 50%; black: >50%. The 48 ORFs of Lv1 are correlative-
ly numbered, indicated by arrows proportional to their length and pointing towards their direction of transcription. The code of the functional modules detect-
ed is indicated at the bottom of (A). Above the scheme, the names of several putatively or experimentally identified genes are shown. (B) Nucleotide
sequence of the region between the putative cI and cro. Consensus promoter sequences (–35 and –10 boxes), the starts of translation, and the operator regions
are indicated.
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The major tail protein is encoded by ORF9, as deduced
from the homology of its product with others of similar func-
tion and, especially, by its correspondence to the peptides
obtained by MALDI-TOF/TOF of the second most abundant
virion protein (Fig. 2C). The apparent size of this protein, 25
kDa, coincides quite well with the predicted 22.3 kDa of gp9.
Gp11 is postulated to be the tape-measure protein and, as
expected, its secondary structure is almost exclusively α-helix.
Between the major tail and the tape-measure genes lies ORF10,
which does not have the translational frameshift site frequently
encountered in this position in other dsDNA phages [38].
ORF13 encodes a long polypeptide of 972 residues that pres-
ents a motif for putative phage antireceptors. This and its local-
ization in the genome suggest that it is the tail-tip protein, usu-
ally involved in host recognition. 
The lysis cassette appears to extend from ORF16 to
ORF19. A promoter-like sequence is placed 5′ of the cluster,
suggesting that these genes are expressed as an operon. Gp16
might be considered to be a class I phage holin because it
presents three transmembrane domains and a predicted N-
out, C-in topology [39]. Moreover, it harbors two adjacent
start codons, suggestive of a holin-antiholin lysis regulatory
mechanism in Lv1, as is true for phage λ [39]. The phage
endolysin is predicted to be encoded by ORF19, which pres-
ents a glycoside hydrolase motif that would confer lysozyme
activity to gp19. The products of the intervening genes,
ORF17 and ORF18, do not match any of the sequences or
motifs stored in the databases.
The stretch from ORF20 to ORF23 exhibits several fea-
tures typical of lysogenic conversion genes (morons), such as
a disparate G+C content (31% vs. 37% for the phage as a
whole), no identity with described sequences, and a location
between the lysis cassette and the attP site, which is prefer-
entially occupied by virulence determinants in Staphy-
lococcus aureus and Streptococcus pyogenes prophages [6].
The genetic switch of the phage may be executed by the
alternative expression of ORF26 and ORF27, which encode,
respectively, CI- and Cro-like repressors that present helix-
turn-helix motifs in their amino-terminal ends. These genes
are separated by a 168-bp intergenic region that contains two
divergently oriented promoters and three stretches of
hyphenated symmetry that might act as operators (Fig. 3B)
[14,29]. Downstream of ORF26, and separated from it by a
small gene lies a determinant containing the motifs of Cre
integrases [33]. It is followed by a 385-bp non-coding stretch
that might constitute the attP sequence, based not only on its
location but also on its high A+T content (73%) and the pres-
ence of direct and inverted repeats. Following the cro deter-
minant, a putative antirepressor gene and several ORFs with-
out relatives in the databases are located.
The replication cluster seems to expand from ORF34 to
ORF39, with the functions deduced from their protein
sequences as follows: DnaA (ORF34), DnaC (ORF36), sin-
gle-stranded DNA-binding determinant (ORF37), and RusA
resolvase (ORF39). 
In the last 4.5 kb of the Lv1 genome are nine ORFs, most
of which do not have counterparts in the databases. One
exception is ORF44, which encodes an ArpU-related protein.
ArpU is thought to control the export of muramidase-2, a
peptidoglycan hydrolase found in the peptidoglycan of
Enterococcus hirae [19]. The other two exceptions are
ORF47 and ORF48, whose products have partial homology
with putative proteins of other lactic acid bacteria phages and
which might encode a methylase and an endonuclease,
respectively.
Overall comparison of the genome of Lv1 with those of
other phages revealed a general similarity with respect to the
functional modules present and to their order in the genome.
However, significant sequence homologies were found only
with the proteins encoded by adh, a phage that infects L. gas-
seri strains [1], and with Sal2, a prophage detected in the
genome of a L. salivarius strain and which is inducible with
mitomycin C, although it is not known whether infective
progeny are produced [35]. This relatedness is mainly
restricted to the left half of the genome, i.e., the terminases
and the structural protein cluster (Fig. 3A). 
Observation of Lv1 virion suspensions indicated that the
junction capsid-tail is unstable and, accordingly, that it is a
defective phage. If this were indeed so, then genetic differ-
ences between Lv1 (and possibly Sal2) and the proficient adh
would be expected. These would presumably involve the
structural region of the genome and, more precisely, the
stretch limited by the major head and major tail protein deter-
minants, where the genes that putatively encode the proteins
of the neck region are located. However, in all three phages
this region encodes four short polypeptides, such that it is
essentially impossible to recognize differences that might
account for the different phenotypes observed. Nevertheless,
the genome of adh is longer (43.8 kb) than those of Sal2
(40.3 kb) and Lv1 (38.9 kb), suggesting that the latter two
suffered deletions affecting their infectivity. According to the
maps shown in Fig. 3A, the gene shortage is located mainly
in the right half of the genomes. The replication cluster and a
series of orfs, mostly with undefined functions, are located in
this stretch. As Lv1 is clearly able to replicate its own DNA,
the defect should be attributed to the surrounding genes.
Although this possibility cannot be excluded, it is improba-
ble because no gene involved in the architecture of the virion
is located in the right half of the phage genome. Furthermore,
most deletion mutants obtained upon treatment of phages as
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dissimilar as (φ)C31 of Streptomyces and A2 of Lactobacillus
casei with chelating agents, have lost DNA in this region
[11,18], indicating that this region does not contain essential
genes. However, the reduced genome size might still account
for the defectiveness of Lv1, due to the packaging constraints
shown by phages with cohesive ends. In the case of lambda,
effective packaging only proceeds when the DNA molecule
to be introduced into the capsid is between 78% and 105% of
the unit-genome length [13], while in (φ)C31 the packaging
limits are 91% and 103% [11]. The genome of Lv1 is 11.2%
shorter than that of adh, while their capsids have similar sizes
(58.8 + 07 nm vs. 62 nm) [23,30]. Therefore, it appears to be
the deletion itself, rather than the genes affected, that has
converted Lv1 into a defective phage.
The classification of Lv-1 into the family Siphoviridae,
together with the presence of cohesive ends in its genome
and of one gene whose product is processed to yield the scaf-
folding and major capsid proteins, allows its inclusion in a
widely represented group of viruses that infect gram-positive
bacteria, as represented by Sfi21 of Streptococcus thermo-
philus [7].
Acknowledgements. This work was supported by the CICYT grants
BFU2007-65781 and AGL2010-15097 from the Spanish Ministry of
Science and Technology and the EU-FEDER Plan. S.E. and R.M. are hold-
ers respectively of a fellowship associated with the former grant and a schol-
arship from FICYT (Principado de Asturias). We thank Alfredo F. Braña for
the generous gift of the antitumor drugs.
References
1. Altermann E, Klein JR, Henrich B (1999) Primary structure and featu-
res of the genome of the Lactobacillus gasseri temperate phage jadh.
Gene 236:333-346
2. Altermann E, Russell WM, Azcarate-Peril MA, et al. (2005) Complete
genome sequence of the probiotic lactic acid bacterium Lactobacillus
acidophilus NCFM. Proc Natl Acad Sci USA 102:3906-3912
3. Antonio MAD, Rabe LK, Hillier SL (2005) Colonization of the rectum
by Lactobacillus species and decreased risk of bacterial vaginosis. J
Infect Dis 192:394-398
4. Azcarate-Peril MA, Altermann E, Goh YJ, et al. (2008) Analysis of the
genome sequence of Lactobacillus gasseri ATCC 33323 reveals the
molecular basis of an autochthonous intestinal organism. Appl Environ
Microbiol 74:4610-4625
5. Boris S, Barbés C (2000) Role played by lactobacilli in controlling the
population of vaginal pathogens. Microbes Infect 2:543-546
6. Brüssow H (2006) Prophage genomics. In: Calendar R (ed) The bacte-
riophages, 2nd ed. Oxford University Press, New York, pp 17-25
7. Brüssow H, Desiere F (2001) Comparative phage genomics and the
evolution of Siphoviridae: insights from dairy phages. Mol Microbiol
39:213-222
8. Brüssow H, Suárez JE (2006) Lactobacillus phages. In: Calendar R (ed)
The bacteriophages, 2nd ed. Oxford University Press, New York, pp
653-666
9. Carta G, Di Stefano L, Porzio G, Caserta D, Mascaretti G (1995)
Bacterial vaginosis during chemotherapy for gynecological neoplasms.
A therapeutic proposal. Minerva Ginecol 47:5-8
10. Casjens SR, Gilcrease EB, Winn-Stapley DA, et al. (2005) The general-
ized transducing Salmonella bacteriophage ES18: complete genome
sequence and DNA packaging strategy. J Bacteriol 187:1091-1104
11. Chater KF, Bruton CJ, Springer W, Suárez JE (1981) Dispensable
sequences and packaging constraints of DNA from the Streptomyces
temperate phage ϕC31. Gene 15:249-256
12. Ewing B, Green P (1998) Base-calling of automated sequencer traces
using phred. II Error probabilities. Genome Res 8:186-194
13. Feiss M, Fisher RA, Crayton MA, Egner C (1977) Packaging of the bac-
teriophage lambda chromosome: effect of chromosome length. Virology
77:281-293 
14. García P, Ladero V, Alonso JC, Suárez JE (1999) Cooperative interac-
tion of CI protein regulates lysogeny of Lactobacillus casei by bacterio-
phage A2. J Virol 73:3920-3929
15. García P, Rodríguez I, Suárez JE (2004) A –1 ribosomal frameshift in
the transcript that encodes the major head protein of bacteriophage A2
mediates biosynthesis of a second essential component of the capsid. J
Bacteriol 186:1714-1719
16. Hillier SL, Nugent RP, Eschenbach DA, et al. (1995) Association
between bacterial vaginosis and preterm delivery of a low-birth-weight
infant. N Engl J Med 333:1737-1742
17. Janion C (2001) Some aspects of the SOS response system: a critical
survey. Acta Biochim Pol 48:599-610
18. Ladero V, García P, Bascarán V, Herrero M, Alvarez M, Suárez JE
(1998) Identification of the repressor-encoding gene of the Lacto-
bacillus bacteriophage A2. J Bacteriol 180:3474-3476
19. Lleó MM, Fontana R, Solioz M (1995) Identification of a gene (arpU)
controlling muramidase-2 export in Enterococcus hirae. J Bacteriol
177:5912-5917 
20. Lo TC, Shih TC, Lin CF, Chen HW, Lin TH (2005) Complete genomic
sequence of the temperate bacteriophage ϕAT3 isolated from
Lactobacillus casei ATCC 393. Virology 339:42-55
21. Lombó F, Menéndez N, Salas JA, Méndez C (2006) The aureolic acid
family of antitumor compounds: structure, mode of action, biosynthesis,
and novel derivatives. Appl Microbiol Biotechnol 73:1-14
22. Madera C, García P, Rodríguez A, Suárez JE, Martínez B (2009)
Prophage induction in Lactococcus lactis by the bacteriocin
Lactococcin 972. Int J Food Microbiol 129:99-102
23. Martín R, Soberón N, Escobedo S, Suárez JE (2009) Bacteriophage
induction versus vaginal homeostasis: role of H2O2 in the selection of
Lactobacillus defective prophages. Int Microbiol 12:131-136
24. Martín R, Soberón N, Vaneechoutte M, Flórez AB, Vázquez F, Suárez
JE (2008) Characterization of indigenous vaginal lactobacilli from
healthy women as probiotic candidates. Int Microbiol 11:261-266
25. Martín R, Suárez JE (2010) Biosynthesis and degradation of H2O2 by
vaginal lactobacilli. Appl Environ Microbiol 76:400-405
26. McLean NW, Rosenstein IJ (2000) Characterization and selection of a
Lactobacillus species to re-colonize the vagina of women with recurrent
bacterial vaginosis. J Med Microbiol 49:543-552
27. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN
(2004) SOS response induction by β-lactams and bacterial defense
against antibiotic lethality. Science 305:1629-1631
28. Pavlova SI, Tao L (2000) Induction of vaginal Lactobacillus phages by
the cigarette smoke chemical benzo[a]pyrene diol epoxide. Mutat Res
466:57-62
29. Ptashne M (1992). A genetic switch, 2nd ed. Cell Press and Blackwell
Scientific Publications, Cambridge, MA, USA
30. Raya RR, Kleeman EG, Luchansky JB, Klaenhammer TR (1989)
Characterization of the temperate bacteriophage jadh and plasmid trans-
MARTÍN ET AL.
121INT. MICROBIOL. Vol.13, 2010
duction in Lactobacillus acidophilus ADH. Appl Environ Microbiol 55:
2206-2213
31. Redondo-López V, Cook RL, Sobel JD (1990) Emerging role of lacto-
bacilli in the control and maintenance of the vaginal bacterial micro-
flora. Rev Infect Dis 12:856-872
32. Soberón N, Martín R, Suárez JE (2007) New method for evaluation of
genotoxicity, based on the use of real-time PCR and lysogenic Gram-
positive and Gram-negative bacteria. Appl Environ Microbiol 73:
2815-2819
33. Swalla BM, Gumport RI, Gardner JF (2003) Conservation of structure and
function among tyrosine recombinases: homology-based modeling of the
lambda integrase core-binding domain. Nucleic Acids Res 31: 805-818
34. Tomasz M (1995) Mitomycin C: small, fast and deadly (but very selec-
tive). Chem Biol 2:575–579
35. Ventura M, Canchaya C, Bernini V, et al. (2006) Comparative genomics
and transcriptional analysis of prophages identified in the genomes of
Lactobacillus gasseri, Lactobacillus salivarius, and Lactobacillus casei.
Appl Environ Microbiol 72:3130-3146
36. Von Gruenigen VE, Coleman RL, Li AJ, Heard MC, Miller DS, Hemsell
DL (2000) Bacteriology and treatment of malodorous lower reproduc-
tive tract in gynecologic cancer patients. Obstet Gynecol 96:23-27
37. Walker GC (1987) The SOS response of Escherichia coli. In: Ingraham
JL, et al. (eds) Escherichia coli and Salmonella typhimurium: cellular
and molecular biology. ASM Press, Washington, DC, pp 1346-1357
38. Xu J, Hendrix RW, Duda RL (2004) Conserved translational frameshift
in dsDNA bacteriophage tail assembly genes. Mol Cell 16:11-21
39. Young R, Wang IN (2006) Phage lysis. In: Calendar R (ed) The bac-
teriophages, 2nd ed. Oxford University Press, New York, pp 104-125 
40. Zhou X, Bent S, Schneider M, Davis C, Islam M, Forney L (2004)
Characterization of vaginal microbial communities in adult healthy
women using cultivation-independent methods. Microbiology 150:
2565-2573
PROPHAGE FROM VAGINAL L. JENSENII
  1
 
Table S1. Characteristics of bacteriophage Lv1 orfs and their deduced gene products 
ORF From To Length aa kDa (pI) 
Predictive 
function 
Closest hit    
(E value) 
% aa identity 
(% similarity) 
Accession 
number 
Predicted domain (E value) 
1 98 631 534 177 
19749.47 
(8.48) 
Terminase 
small subunit 
Lactobacillus 
fermentum 
IFO 3956 (9e-
41) 
52% (77%) YP_001843285| 
Terminase_4 (PF05119)(2.8e-25); 
Phage terminase, small subunit 
(TIGR1558)( 1e-18 ) 
2 631 2535 1905 634 
74178.16 
(5.86) 
Terminase 
large subunit 
Lactobacillus 
fermentum 
IFO 3956 
(0.0) 
67% (82%) YP_001843286.1| 
Terminase_1 (PF03354) (2.2e-115); 
TMHMM transmembrane regions 
3 2545 3705 1161 386 
42207.74 
(4.85) 
Phage portal 
protein 
Lactobacillus 
fermentum 
IFO 3956 (5e-
97) 
48% (72%) YP_001843288.1| 
Phage portal protein, HK97 ( 
TIGR01537) (4.4e-48); Phage portal 
protein (PF04860) (2.3e-56 ) 
4 3811 5658 1848 615 
68706.56 
(4.86) 
Phage capsid 
protein 
Lactobacillus 
fermentum  
46% (63%) YP_001843289.1| 
Peptidase U35, phage prohead 
HK97 (PF04586) (3e-48);  
 
MARTIN R, ET AL. (2010) INT MICROBIOL 13:113‐121  
DOI: 10.2436/20.1501.01.116 
  2
IFO 3956 (2e-
98) 
Proheadase_HK97: phage prohead 
protease, (TIGR01543) (6.9e-26); 
Phage major capsid protein, HK97 
(PF05065) (5.8e-31); Phage major 
capsid protein (TIGR01554) (5.9e-
41) 
5 5680 5779 300 99 
11100.59 
(4.59) 
Unknown     
6 5962 6333 372 123 
13765.60 
(8.76) 
Head-tail 
joining 
protein 
Lactobacillus 
phage ΦAT3 
(8e-08) 
30% (57%) YP_025033.1| 
Phage head-tail joining (PF05521) 
(3.8e-07); Phage head-tail adaptor, 
putative (TIGR01563) (0.00025) 
7 6284 6784 501 166 
18279.54 
(5.35) 
Head-tail 
joining 
protein 
Lactobacillus 
phage ΦAT3 
(7e-05) 
28% (45%) YP_025034.1| 
Phage head/tail component 
(PF04883) (2e-05) 
8 6777 7157 384 127 
14689.42 
(4.55) 
Head-tail 
joining 
protein 
Lactobacillus 
phage ΦAT3 
(6e-13) 
35% (54%) YP_025035.1|  
9 7160 7789 630 209 
22264.79 
(5.44) 
Major tail 
protein 
Lactobacillus 
phage Φadh 
(1e-27) 
37% (55%) NP_050156.1| 
Phage major tail protein (PF04630) 
(1.6e-22); Signalp signal-peptide 
  3
10 7875 8489 645 204 
23216.39 
(5.33) 
Tail protein 
Lactobacillus 
phage Φadh 
(3e-07) 
29% (44%) NP_050157.1|  
11 8663 13345 4683 1560 
168134.97 
(9.78) 
Tape 
measure 
protein 
Lactobacillus 
rhamnosus Lc 
Nu-like 
prophage (0.0) 
30% (48%) 
AAX07957.1| 
 
Lytic transglycosylase-like, catalytic 
(PF01464) (0.00088); Tape measure 
domain (TIGR02675) (4.2e-05) 
12 13470 14072 603 200 
23359.45 
(5.25) 
Tail protein 
Enterococcus 
faecalis V583 
(2e-14) 
30% (49%) NP_815672.1|  
13 14069 16852 2784 927 
100922.12 
(4.95) 
Fiber tail 
protein 
Lactobacillus 
phage Φadh 
(8e-53) 
47% (68%), NP_050162.1|  
14 17024 18934 1914 637 
70997.65 
(7.52) 
Minor capsid 
protein 
Lactobacillus 
phage Φg1e 
(1e-10) 
31% (52%) NP_695155.1|  
15 18961 19425 465 154 
16820.78 
(4.57) 
Unknown     
16 19576 19968 393 130 
14608.35 
(9.21) 
Holin Lactobacillus 
phage Lc-Nu 
30% (53%) YP_358776.1| 
Signalp signal-peptide; 
Transmembrane regions 
  4
(2e-10) 
17 19987 20220 234 77 
9214.87 
(10.16) 
Unknown    Signalp signal-peptide 
18 20400 20792 393 130 
14269.59 
(6.59) 
Unknown    
Signalp signal-peptide; 
Transmembrane regions 
19 20808 21929 1122 373 
40957.01 
(5.54) 
Lysin 
(lysozyme) 
Lactococcus 
lactis (3e-29) 
32% (50%) CAA10710.1| 
Glycoside hydrolase, family 25 
(PD004620) (7e-19); 
Glyco_hydro_25 2. (PF01183) (3e-
15); Glycoside hydrolase, catalytic 
core (G3DSA:3.20.20.80) (2.6e-27) 
20 22421 22645 225 74 
8108.60 
(9.87) 
Unknown     
21 22891 23322 432 143 
16990.89 
(5.36) 
Unknown     
22 23334 23525 192 63 
7720.57 
(9.22) 
Unknown     
23 23607 24071 465 154 
17782.38 
(4.05) 
Unknown     
24 25562 24456 1107 368 41823.25 Phage 
Lactobacillus 
salivarius 
35% (55%) YP_535622.1| N-6 adenine-specific DNA 
methylase, conserved site 
  5
(9.82) integrase UCC118 (9e-
58) 
(PS00092); Integrase, catalytic core, 
phage (PF00589) ( 5.5e-24); 
integrase-like, catalytic core, phage 
(G3DSA:1.10.443.10) (7e-31) 
25 25979 25653 327 108 
11934.51 
(5.56) 
Unknown     
26 26956 26297 660 219 
24066.32 
(5.13) 
CI-like 
repressor 
Lactobacillus 
reuteri 100-
23(1e-41) 
46% (61%) ZP_01274778.1| 
Helix-turn-helix type 3 (PS50943) 
(9.844); Peptidase S24, S26A and 
S26B, C-terminal 
(G3DSA:2.10.109.10) (1.1e-20), 
(PF00717) (1.2e-14) 
27 27124 27354 231 76 
8671.15 
(9.79) 
Cro-like 
repressor 
Lactobacillus 
phage Sal2 
(1e-04) 
41% (62%) YP_535148.1| 
Helix-turn-helix type 3 (PF01381) 
(2.8e-13), (SM00530) (1.2e-10), 
(PS50943) (13.603) 
28 27374 28201 828 275 
30370.81 
(9.19) 
Antirepressor 
Lactobacillus 
prophage 
Lj928 (2e-
100) 
75% (84%) NP_958516.1| 
BRO, N-terminal (PF02498) (1e-
37); Phage antirepressor protein 
(PF03374) (2.8e-72) 
29 28979 28362 621 206 
23298.98 
(7.01) 
Unknown    Transmembrane regions 
  6
30 29059 29328 273 90 
10894.25 
(5.78) 
Unknown     
31 29641 30165 525 174 
20066.09 
(4.68) 
Unknown     
32 30168 30500 330 110 
13308.29 
(9.42) 
Unknown     
33 30517 30726 210 69 
8068.69 
(9.45) 
Unknown    
Signalp signal-peptide; 
Transmembrane regions 
34 30840 31589 750 249 
28983.03 
(9.66) 
DnaA 
Lactobacillus 
phage LL-H 
(1e-38) 
36% (54%) ref|YP_001285918.1| 
Phage conserved hypothetical 
protein, C-terminal (TIGR02220) 
(9e-39) 
35 31592 32026 435 144 
16839.02 
(6.73) 
Unknown     
36 32010 32819 813 270 
30925.33 
(8.55) 
DnaC 
Lactobacillus 
phage LL-H 
(3e-45) 
37% (61%) ref|YP_001285919.1| 
AAA+ ATPase, core (SM00382) 
(1.8e-05) 
37 32801 33292 492 163 
18309.37 
(4.94) 
Single 
stranded 
DNA 
binding 
Lactobacillus 
sakei subsp. 
sakei 23K (4e-
40) 
48% (67%) YP_394621.1| 
Primosome PriB/single-strand DNA-
binding (PF00436) (3.3e-34),  
(PS50935); Single-strand DNA-
binding (PTHR10302) (9.7e-28) 
(TIGR00621) (2.5e-43); Nucleic 
  7
protein acid-binding, OB-fold 
(G3DSA:2.40.50.140) (1.1e-36) 
38 33246 33908 663 220 
25493.10 
(9.11) 
Unknown     
39 34024 34317 294 97 
11079.84 
(7.71) 
RusA 
resolvase 
Lactobacillus 
reuteri 100-23 
(2e-25) 
42% (68%) ZP_01273467.1| 
Endodeoxyribonuclease, RusA-like 
(PF05866) (1.1e-11) 
40 34314 34625 312 103 
11863.78 
(7.64) 
Unknown     
41 34633 35415 783 260 
30623.38 
(7.70) 
Unknown    Transmembrane regions 
42 35405 35647 243 80 
9243.22 
(9.72) 
Unknown    Transmembrane regions 
43 35631 35840 210 69 
8290.39 
(4.98) 
Unknown     
44 35844 36317 474 157 
18007.66 
(8.57) 
Arp-U-like 
protein 
Lactobacillus 
reuteri 100-23 
(1e-14) 
30% (55%) ZP_01274484.1| 
Phage transcriptional activator ArpU 
(TIGR01637) (3e-21) 
45 36223 36627 405 134 
15488.60 
(4.51) 
Unknown     
  8
46 36509 36697 189 62 
7196.34 
(10.42) 
Unknown     
47 37292 38419 1128 375 
43678.20 
(8.83) 
DNA 
methylase 
Lactobacillus 
phage Lc-Nu 
(7e-48) 
43% (62%) YP_358799.1|  
48 38428 38892 465 154 
18256.08 
(9.59) 
HNH 
nuclease 
Lactobacillus 
phage Lc-Nu 
(1e-13) 
35% (50%), 
YP_358809.1| 
 
HNH endonuclease (PF01844) 
(0.00036); HNH nuclease 
(SM00507) (0.033) 
 
